A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2001
10/18/2001	CA2403012A1 Chemical compounds
10/18/2001	CA2372352A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144459A2 Cross-linked hyaluronic acids and medical uses thereof
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144435A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144411A1 Antihistaminic spiro compounds
10/17/2001	EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001	EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001	EP1144390A2 Kinase inhibitors
10/17/2001	EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001	EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001	EP1144386A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/17/2001	EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144370A2 Thyroid receptor ligands
10/17/2001	EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001	EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
10/17/2001	EP1143973A2 Compositions having improved stability
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP1143964A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
10/17/2001	EP1143935A2 Controlled-release biocompatible ocular drug delivery implant devices and methods
10/17/2001	EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001	EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
10/17/2001	EP0966281B1 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure
10/17/2001	EP0751766B1 Nasal and ocular administration of ketamine to manage pain and for detoxification
10/17/2001	EP0652871B1 Benzodiazepine derivatives
10/17/2001	CN1318059A Isoquinolines as urokinase inhibitors
10/17/2001	CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
10/17/2001	CN1318054A Novel compounds
10/17/2001	CN1317979A Serotonergic 5HT2 agonists for treating glaucoma
10/17/2001	CN1317342A Eye preparation
10/17/2001	CN1317335A Medical pill for improving vision and clearing liver heat away
10/17/2001	CN1317334A Ointment for treating myopia and its preparing process
10/16/2001	US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001	US6303658 Therapy of ocular hypertension by applying cyclopentane heptenoic acid or heptanoic acid and/or derivative
10/16/2001	US6303655 Administering n-(3,4-dimethoxycinnamoyl)anthranilic acid or its salt for therapy of diseases associated with excessive proliferation of retinal pigment epithilial cells
10/16/2001	US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative
10/16/2001	US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system
10/16/2001	US6303631 Water-soluble eye drop
10/16/2001	US6303615 2,3 disubstituded-4(3H)-quinazolinones
10/16/2001	US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/11/2001	WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
10/11/2001	WO2001074896A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	WO2001074835A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001	WO2001074834A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001	WO2001074812A1 Novel benzosultam oxazolidinone antibacterial agents
10/11/2001	WO2001074807A1 Indolylpyrrole derivatives and cell death inhibitors
10/11/2001	WO2001074797A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands
10/11/2001	WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001	WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001	WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001	WO2001074400A1 Transporters and drug delivery system by using the same
10/11/2001	WO2001074389A2 Improved treatment of neovascularization
10/11/2001	WO2001074381A2 Calpain inhibitors in cancer treatment
10/11/2001	WO2001074379A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	WO2001074369A1 Divided dose therapies with vascular damaging activity
10/11/2001	WO2001074360A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001	WO2001074359A1 Sigma receptor ligands and their medical uses
10/11/2001	WO2001074330A2 Method for treating dry eye
10/11/2001	WO2001074314A2 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
10/11/2001	WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
10/11/2001	US20010029304 Cyclopentane heptan (ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
10/11/2001	US20010029269 Non-steroidal antiinflammatory agent
10/11/2001	US20010029265 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
10/11/2001	US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase
10/11/2001	DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001	CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001	CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	CA2404475A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands
10/11/2001	CA2404376A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001	CA2404373A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001	CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	CA2403885A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001	CA2403612A1 Improved treatment of neovascularization
10/11/2001	CA2402586A1 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	CA2402078A1 Divided dose therapies with vascular damaging activity
10/11/2001	CA2401888A1 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
10/11/2001	CA2401854A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001	CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001	CA2399275A1 Novel benzosultam oxazolidinone antibacterial agents
10/10/2001	EP1142890A1 Aminopyrazole derivatives
10/10/2001	EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001	EP1142880A1 Benzimidazole derivatives
10/10/2001	EP1142585A1 Remedies for corneal disorders
10/10/2001	EP1142566A1 Compositions for ophtalmic use containing cyclosporin, hyaluronic acid and polysorbate
10/10/2001	EP1141386A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
10/10/2001	EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors
10/10/2001	EP1141308A2 Group b streptococcus proteins, and their use
10/10/2001	EP1141306A2 Streptococcus antigens
10/10/2001	EP1141287A1 Pancreatic polypeptide zsig66
10/10/2001	EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001	EP1141240A1 Use of cd40 engagement to alter t cell receptor usage

1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 531